Peer review reports
From: High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
Original Submission |
7 Sep 2012 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
1 Oct 2012 |
Author responded |
Author comments - Emman Shubbar
|
Resubmission - Version 3 |
1 Oct 2012 |
Submitted |
Manuscript version 3
|
1 Oct 2012 |
Reviewed |
Reviewer Report - Joseph Bertino
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
6 Nov 2012 |
Reviewed |
Reviewer Report - Arto Mannermaa
|
25 Nov 2012 |
Author responded |
Author comments - Emman Shubbar
|
Resubmission - Version 8 |
25 Nov 2012 |
Submitted |
Manuscript version 8
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
11 Dec 2012 |
Author responded |
Author comments - Emman Shubbar
|
Resubmission - Version 10 |
11 Dec 2012 |
Submitted |
Manuscript version 10
|
Publishing |
30 Jan 2013 |
Editorially accepted |
|
1 Feb 2013 |
Article published |
10.1186/1471-2407-13-47
|
Learn about peer review